<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK5313" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK5313/" /><meta name="ncbi_pagename" content="Congenital Dyserythropoietic Anemia Type I - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Congenital Dyserythropoietic Anemia Type I - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Congenital Dyserythropoietic Anemia Type I" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/08/25" /><meta name="citation_author" content="Hannah Tamary" /><meta name="citation_author" content="Orly Dgany" /><meta name="citation_pmid" content="20301759" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK5313/" /><meta name="citation_keywords" content="Codanin-1" /><meta name="citation_keywords" content="Protein C15orf41" /><meta name="citation_keywords" content="C15orf41" /><meta name="citation_keywords" content="CDAN1" /><meta name="citation_keywords" content="Congenital Dyserythropoietic Anemia Type I" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Congenital Dyserythropoietic Anemia Type I" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Hannah Tamary" /><meta name="DC.Contributor" content="Orly Dgany" /><meta name="DC.Date" content="2016/08/25" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK5313/" /><meta name="description" content="Congenital dyserythropoietic anemia type I (CDA I) is characterized by moderate-to-severe macrocytic anemia presenting occasionally in utero as severe anemia associated with hydrops fetalis but more commonly in neonates as hepatomegaly, early jaundice, and intrauterine growth retardation. Some cases present in childhood or adulthood. After the neonatal period, most affected individuals have lifelong moderate anemia, usually accompanied by jaundice and splenomegaly. Secondary hemochromatosis develops with age as a result of increased iron absorption even in those who are not transfused. Distal limb anomalies occur in 4%-14% of affected individuals." /><meta name="og:title" content="Congenital Dyserythropoietic Anemia Type I" /><meta name="og:type" content="book" /><meta name="og:description" content="Congenital dyserythropoietic anemia type I (CDA I) is characterized by moderate-to-severe macrocytic anemia presenting occasionally in utero as severe anemia associated with hydrops fetalis but more commonly in neonates as hepatomegaly, early jaundice, and intrauterine growth retardation. Some cases present in childhood or adulthood. After the neonatal period, most affected individuals have lifelong moderate anemia, usually accompanied by jaundice and splenomegaly. Secondary hemochromatosis develops with age as a result of increased iron absorption even in those who are not transfused. Distal limb anomalies occur in 4%-14% of affected individuals." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK5313/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/cda1/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK5313/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE888AD1E03F3CE1000000000959033D.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK5313_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK5313_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cdg/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cep/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK5313_"><span class="title" itemprop="name">Congenital Dyserythropoietic Anemia Type I</span></h1><p class="contrib-group"><span itemprop="author">Hannah Tamary</span>, MD and <span itemprop="author">Orly Dgany</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK5313_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK5313_ai__"><div class="contrib half_rhythm"><span itemprop="author">Hannah Tamary</span>, MD<div class="affiliation small">Professor of Pediatrics<br />Head of Pediatric Hematology Unit<br />Schneider Children's Medical Center of Israel<br />Petah Tiqva, Israel</div></div><div class="contrib half_rhythm"><span itemprop="author">Orly Dgany</span>, PhD<div class="affiliation small">Director, Pediatric Hematology Laboratory<br />Felsenstein Medical Research Center<br />Beilinson Campus<br />Petah Tiqva, Israel</div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">April 21, 2009</span>; Last Update: <span itemprop="dateModified">August 25, 2016</span>.</p><p><em>Estimated reading time: 14 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="cda1.Summary" itemprop="description"><h2 id="_cda1_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Congenital dyserythropoietic anemia type I (CDA I) is characterized by moderate-to-severe macrocytic anemia presenting occasionally in utero as severe anemia associated with hydrops fetalis but more commonly in neonates as hepatomegaly, early jaundice, and intrauterine growth retardation. Some cases present in childhood or adulthood. After the neonatal period, most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have lifelong moderate anemia, usually accompanied by jaundice and splenomegaly. Secondary hemochromatosis develops with age as a result of increased iron absorption even in those who are not transfused. Distal limb anomalies occur in 4%-14% of affected individuals.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Diagnosis of CDA I is suspected based on hematologic findings and established with identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>CDAN1</i> or <i>C15orf41</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Intramuscular or subcutaneous injections of interferon (IFN)-&#x003b1;<sub>2a</sub> or INF-&#x003b1;<sub>2b</sub> given two or three times a week increase hemoglobin and decrease iron overload in the majority of treated individuals. Successful allogenic bone marrow transplantation has been described in three children and should be considered only in those transfusion-dependent persons who are resistant to IFN therapy.</p><p><i>Prevention of secondary complications</i>: Treatment of iron overload using standard guidelines for regular phlebotomy and iron chelation as needed.</p><p><i>Surveillance</i>: Recommended monitoring for iron overload:</p><ul><li class="half_rhythm"><div>Measurement of hemoglobin, bilirubin, iron, transferrin and serum ferritin concentration every three months starting at age ten years.</div></li><li class="half_rhythm"><div>Annual myocardial T<sub>2</sub>* MRI and hepatic R<sub>2</sub>* MRI (if available) starting at age ten years.</div></li></ul><p><i>Agents/circumstances to avoid</i>: Any preparation containing iron.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>CDA I is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Once the pathogenic variants have been identified in an affected family member, <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for at-risk relatives and prenatal testing for pregnancies at increased risk are possible options.</p></div></div><div id="cda1.Diagnosis"><h2 id="_cda1_Diagnosis_">Diagnosis</h2><div id="cda1.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Congenital dyserythropoietic anemia type I (CDA I) <b>should be suspected</b> in individuals with the following findings:</p><ul><li class="half_rhythm"><div>Moderate-to-severe macrocytic anemia with MCV &#x0003e;90 fL</div></li><li class="half_rhythm"><div>Inappropriately low number of reticulocytes for the degree of anemia compared to other hemolytic anemias (secondary to ineffective erythropoiesis)</div></li><li class="half_rhythm"><div>On peripheral blood smear: macrocytosis, elliptocytes, basophilic stippling, and occasional mature nucleated erythrocytes</div></li><li class="half_rhythm"><div>In bone marrow aspirate:</div><ul><li class="half_rhythm"><div>On light microscopy: erythroid hyperplasia, few double-nucleated erythroblasts, and interchromatin bridges between erythroblasts (in 0.6%-2.8% of erythroblasts)</div></li><li class="half_rhythm"><div>On electron microscopy: erythroid precursors with spongy appearance of heterochromatin (in &#x02264;60% of erythroblasts) and invaginations of the nuclear membrane</div></li></ul></li><li class="half_rhythm"><div>Other:</div><ul><li class="half_rhythm"><div>Jaundice</div></li><li class="half_rhythm"><div>Splenomegaly resulting from marrow expansion secondary to ineffective erythropoiesis</div></li><li class="half_rhythm"><div>Anemia and distal limb dimorphism including hypoplastic nails and syndactyly</div></li></ul></li></ul></div><div id="cda1.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of CDA I <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <a href="#cda1.Suggestive_Findings">suggestive findings</a> and identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of the genes listed in <a class="figpopup" href="/books/NBK5313/table/cda1.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figcda1Tmoleculargenetictestingusedin" rid-ob="figobcda1Tmoleculargenetictestingusedin">Table 1</a>.</p><p>Molecular testing approaches can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> can be considered if (1) mutation of a particular gene accounts for a large proportion of the disease <b>or</b> (2) factors including clinical findings, laboratory findings, or ancestry indicate that mutation of a particular gene is most likely.</p><p>Sequence analysis of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> of interest is performed first and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.*</p><ul><li class="half_rhythm"><div>Targeted analysis for the <a class="figpopup" href="/books/NBK5313/table/cda1.T.selected_cdan1_variants/?report=objectonly" target="object" rid-figpopup="figcda1Tselectedcdan1variants" rid-ob="figobcda1Tselectedcdan1variants">c.3124C&#x0003e;T</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CDAN1</i> can be performed first in individuals of Bedouin ancestry.</div></li><li class="half_rhythm"><div>In all other ethnicities, full <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> sequencing of <i>CDAN1</i> should be performed first.</div></li><li class="half_rhythm"><div>If no <i>CDAN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, full sequencing of <i>C15orf41</i> should be performed in all populations.</div></li></ul><p>*Note: The authors are not aware of <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> having been performed on either <i>CDAN1</i> or <i>C15orf41.</i></p><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>C15orf41</i> and <i>CDAN1</i> and other genes of interest (see <a href="#cda1.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>C15orf41</i> and <i>CDAN1</i>) fails to confirm a diagnosis in an individual with features of CDA 1. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation).</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="cda1.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Congenital Dyserythropoietic Anemia Type I (CDA I)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK5313/table/cda1.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cda1.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of CDA1 Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Test Method</th></tr><tr><th headers="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></th><th headers="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>4</sup></th></tr></thead><tbody><tr><td headers="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>C15orf41</i></td><td headers="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~1%&#x000a0;<sup>5</sup></td><td headers="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/3</td><td headers="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CDAN1</i></td><td headers="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">90%&#x000a0;<sup>7</sup></td><td headers="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">97/97</td><td headers="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td><td headers="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9%</td><td headers="hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_2_1 hd_h_cda1.T.molecular_genetic_testing_used_in_1_1_2_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="cda1.TF.1.1"><p class="no_margin">See <a href="/books/NBK5313/#cda1.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="cda1.TF.1.2"><p class="no_margin">See <a href="#cda1.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="cda1.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="cda1.TF.1.4"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>5. </dt><dd><div id="cda1.TF.1.5"><p class="no_margin">Author, personal observation</p></div></dd><dt>6. </dt><dd><div id="cda1.TF.1.6"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd><dt>7. </dt><dd><div id="cda1.TF.1.7"><p class="no_margin">In 60% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals two pathogenic variants were identified by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, in 28% only one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was identified, and in 11% no pathogenic variant was identified (Note: Testing to detect <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants and large deletions was not performed) [Authors and other labs, combined data, unpublished].</p></div></dd><dt>8. </dt><dd><div id="cda1.TF.1.8"><p class="no_margin">The existence of at least one additional <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> is suggested by the absence of pathogenic variants in <i>CDAN1</i> or <i>C15orf41</i> in seven families with CDA I [<a class="bk_pop" href="#cda1.REF.babbs.2013.1383">Babbs et al 2013</a>].</p></div></dd></dl></div></div></div></div></div><div id="cda1.Clinical_Characteristics"><h2 id="_cda1_Clinical_Characteristics_">Clinical Characteristics</h2><div id="cda1.Clinical_Description"><h3>Clinical Description</h3><p><b>Prenatal findings.</b> Rarely, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> dyserythropoietic anemia type I (CDA I) presents as severe in utero anemia that may be associated with hydrops fetalis, requiring intrauterine red blood cell (RBC) transfusion. Prenatal management of pregnancies at risk for complications of CDA I involves monitoring of fetal hemoglobin by Doppler ultrasonography and fetal transfusions to prevent hydrops fetalis if severe fetal anemia is detected.</p><p><b>Neonatal presentation.</b> Of 70 Bedouin neonates with CDA I, 45 (64%) were symptomatic [<a class="bk_pop" href="#cda1.REF.shalev.2004.746">Shalev et al 2004</a>]. Of those with symptoms, 65% had hepatomegaly, 53% had early jaundice, and 27% were small for gestational age. A few had persistent pulmonary hypertension, direct hyperbilirubinemia, and transient thrombocytopenia. The majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants required at least one blood transfusion during the neonatal period.</p><p><b>Childhood and later</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Anemia.</b> Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have lifelong moderate anemia (mean hemoglobin levels 85&#x000b1;6 g/L). Anemia is usually accompanied by jaundice and splenomegaly, which was present in 17 of 21 (80%) individuals [<a class="bk_pop" href="#cda1.REF.heimpel.2006.334">Heimpel et al 2006</a>]. Few are transfusion dependent; <a class="bk_pop" href="#cda1.REF.heimpel.2006.334">Heimpel et al [2006]</a> found that only two of 21 individuals followed for up to 37 years were dependent on transfusion.</div><div class="half_rhythm">Even in those with CDA I who are not transfused, secondary hemochromatosis develops with age as a result of increased iron absorption. Free iron precipitating in parenchymal organs and especially in the heart can cause congestive heart failure and arrhythmias. Low hepcidin levels have been documented in individuals with CDA I.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Splenomegaly</b> may be absent in infants or young children, but develop later with age.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Gallstones</b> were detected in four of 21 individuals before age 30 years.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Skeletal findings.</b> Distal limb anomalies including syndactyly, hypoplastic nails, and duplication of fourth metatarsal bone were described in 4%-14% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Lumbar scoliosis resulting from a partly duplicated L3 vertebra was also described.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Ophthalmic concerns.</b> Retinal angioid streaks with deterioration of vision have been reported is a rare complication of inherited hemolytic anemia in 4 adults aged 45-57 years [<a class="bk_pop" href="#cda1.REF.roberts.2006.456">Roberts et al 2006</a>, <a class="bk_pop" href="#cda1.REF.tamary.2008.271">Tamary et al 2008</a>, <a class="bk_pop" href="#cda1.REF.frimmel.2016.482">Frimmel &#x00026; Kniestedt 2016</a>].</div></li></ul><p><b>Life span.</b> Five (23%) of 21 adult patients described by <a class="bk_pop" href="#cda1.REF.heimpel.2006.334">Heimpel et al [2006]</a> died, mainly as a result of iron overload. According to the authors&#x02019; recently published follow-up data, 9% (3/32) of adult patients died at age 46-59 years. Causes of death included sepsis and severe arterial pulmonary hypertension [<a class="bk_pop" href="#cda1.REF.shalev.2017.13">Shalev et al 2017</a>]. It should be noted that all deceased patients previously underwent splenectomy.</p></div><div id="cda1.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> correlations are known. Marked clinical variability is observed even among individuals with the same pathogenic variants.</p></div><div id="cda1.Prevalence"><h3>Prevalence</h3><p>About 100 <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., single occurrences in a family) mainly from Europe and about 70 <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> Israeli Bedouin families have been described in the literature. <i>C15orf41</i> variants have been described in one family originating in Kuwait and in two South Asian (Pakistani) families [<a class="bk_pop" href="#cda1.REF.babbs.2013.1383">Babbs et al 2013</a>].</p></div></div><div id="cda1.Genetically_Related_Allelic_Disorde"><h2 id="_cda1_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>CDAN1</i> or <i>C15orf41</i>.</p></div><div id="cda1.Differential_Diagnosis"><h2 id="_cda1_Differential_Diagnosis_">Differential Diagnosis</h2><p>The following <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anemias are included in the differential diagnosis of CDA I:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Congenital dyserythropoietic anemia type II</b> (CDA II; OMIM <a href="http://omim.org/entry/224100" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">224100</a>) is the most common CDA. It is also known as HEMPAS (<i>h</i>ereditary <i>e</i>rythroblastic <i>m</i>ultinuclearity with <i>p</i>ositive <i>a</i>cidified <i>s</i>erum lysis test) because the RBCs of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are lysed by acidified sera of 40%-60% of healthy adults due to the presence of natural cold-reacting IgM antibody. CDA II is characterized by mild-to-severe anemia, jaundice, and (in 50%-60% of affected individuals) splenomegaly. Up to 15% of affected individuals are transfusion dependent [<a class="bk_pop" href="#cda1.REF.heimpel.2003.4576">Heimpel et al 2003</a>, <a class="bk_pop" href="#cda1.REF.wickramasinghe.2005.431">Wickramasinghe &#x00026; Wood 2005</a>]. Beyond age 20 years most affected individuals develop iron overload.</div><div class="half_rhythm">The diagnosis of CDA II requires evidence of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anemia, ineffective erythropoiesis, and typical bone marrow findings with binuclearity in 10%-50% of erythroblasts. CDA II is caused by mutation of <i>SEC23B</i> and inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner [<a class="bk_pop" href="#cda1.REF.schwarz.2009.936">Schwarz et al 2009</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Congenital dyserythropoietic anemia type III</b> (CDA III; OMIM <a href="http://omim.org/entry/105600" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">105600</a>) is the rarest CDA. It was first described in 1951 in an American family by Wolfe and von Hofe, and again in 1962 in a large family from northern Sweden [<a class="bk_pop" href="#cda1.REF.wickramasinghe.2005.431">Wickramasinghe &#x00026; Wood 2005</a>]. The clinical presentation is similar to that of CDA I and CDA II; however, in the Swedish family, the anemia is not severe and transfusions are not required. The most marked anomaly in the bone marrow is the presence of giant multinucleated erythroblasts with up to 12 nuclei per cell. Additional findings include retinal angioid streaks, macular degeneration, and monoclonal gammopathy with or without multiple myeloma. The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants were causative was mapped close to <i>CDAN1</i> in a 4.5-cM interval between 15q21 and 15q25. CDA III has been described in fewer than 20 well-documented <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family).</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Congenital dyserythropoietic anemia type IV</b> (CDAN IV; OMIM <a href="http://omim.org/entry/613673" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613673</a>) is caused by mutation of <i>KLF1</i> and inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner<i>.</i></div></li></ul><p><b>Other.</b> The diagnosis of CDA should be considered following exclusion of other causes of macrocytosis (mainly B<sub>12</sub> deficiency and folic acid deficiency) and dyserythropoiesis, including thalassemia syndromes and hereditary sideroblastic anemia. However, the latter two are associated with microcytic anemia.</p></div><div id="cda1.Management"><h2 id="_cda1_Management_">Management</h2><div id="cda1.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> dyserythropoietic anemia type I (CDA I), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Hemoglobin concentration and serum bilirubin concentration</div></li><li class="half_rhythm"><div>Serum ferritin concentration and other modalities used to assess iron overload including liver and myocardial T<sub>2</sub>* MRI and hepatic R<sub>2</sub>* MRI</div></li><li class="half_rhythm"><div>Abdominal ultrasound examination to evaluate for biliary stones</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="cda1.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Intramuscular or subcutaneous injections of interferon (IFN)- <sub>&#x003b1;2a</sub> or INF- <sub>&#x003b1;2b</sub> given two or three times a week increase hemoglobin and decrease iron overload in the majority of treated individuals [<a class="bk_pop" href="#cda1.REF.lavabrebertrand.2004.380">Lavabre-Bertrand et al 2004</a>]. Peginterferon-<sub>&#x003b1;2b</sub> has also been given once a week. The mechanism behind this response is unknown. To date, only a limited number of individuals, including infants, have been treated.Treatment should be given by a physician who is experienced in interferon administration.</p><p>Successful allogenic bone marrow transplantation has been described in three children [<a class="bk_pop" href="#cda1.REF.ayas.2002.681">Ayas et al 2002</a>] and should be considered only in those transfusion-dependent persons who are resistant to IFN therapy.</p><p>Splenectomy is of unproved value; failure of this procedure to increase hemoglobin levels and also thromboembolic complications may follow splenectomy. Therefore, splenectomy should be cautiously considered in patients with CDA I, as is recommended for non-transfusion-dependent thalassemia [<a class="bk_pop" href="#cda1.REF.taher.2013">Taher et al 2013</a>].</p></div><div id="cda1.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>Treatment of iron overload with regular phlebotomies, if possible, along with iron chelators as necessary, is indicated. Iron overload therapy should follow the guidelines used for non-transfusion dependent thalassemia [<a class="bk_pop" href="#cda1.REF.taher.2013">Taher et al 2013</a>].</p></div><div id="cda1.Surveillance"><h3>Surveillance</h3><p>Recommended monitoring for iron overload:</p><ul><li class="half_rhythm"><div>Measurement of hemoglobin, bilirubin, iron, transferrin and serum ferritin concentration every three months starting at age ten years</div></li><li class="half_rhythm"><div>Annual myocardial T<sub>2</sub>* MRI and hepatic R<sub>2</sub>* MRI, if available, starting at age ten years</div></li></ul></div><div id="cda1.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Avoid any preparation containing iron.</p></div><div id="cda1.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>Evaluation of the younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> for early manifestations of CDA I is recommended so that monitoring of hemoglobin and ferritin levels and treatment can begin as soon as necessary in those who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p><ul><li class="half_rhythm"><div>Evaluation of at-risk family members should include CBC to identify macrocytic anemia as well as typical findings on blood smear including macrocytosis, elliptocytes, and basophilic stippling.</div></li><li class="half_rhythm"><div>The diagnosis can be confirmed by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> if the pathogenic variants in the family have been identified.</div></li></ul><p>See <a href="#cda1.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="cda1.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Anemia places pregnancies of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> women at high risk for delivery-related and outcome complications [<a class="bk_pop" href="#cda1.REF.shalev.2008.317">Shalev et al 2008</a>].</p></div><div id="cda1.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="cda1.Genetic_Counseling"><h2 id="_cda1_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="cda1.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Congenital dyserythropoietic anemia type I (CDA I) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="cda1.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>CDAN1</i> or <i>C15orf41</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Unless an individual with CDA I has children with an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual or a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, his/her offspring will be obligate heterozygotes (carriers) for a <i>CDAN1</i> or <i>C15orf41</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>&#x02019;s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>CDAN1</i> or <i>C15orf41</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="cda1.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>CDAN1</i> or <i>C15orf41</i> pathogenic variants in the family.</p><p>In populations with a high <a class="def" href="/books/n/gene/glossary/def-item/carrier-rate/">carrier rate</a> and/or a high rate of <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a>, it is possible that the reproductive partner of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or is a carrier. Thus, the risk to offspring is most accurately determined after <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of the proband's reproductive partner.</p></div><div id="cda1.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#cda1.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="cda1.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>CDAN1</i> or <i>C15orf41</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="cda1.Resources"><h2 id="_cda1_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="https://ghr.nlm.nih.gov/condition/congenital-dyserythropoietic-anemia" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Congenital dyserythropoietic anemia</a></div></li></ul></div><div id="cda1.Molecular_Genetics"><h2 id="_cda1_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="cda1.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Congenital Dyserythropoietic Anemia Type I: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK5313/table/cda1.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cda1.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_cda1.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_cda1.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_cda1.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_cda1.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_cda1.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_cda1.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_cda1.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/84529" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>C15orf41</i></a></td><td headers="hd_b_cda1.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=84529" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">15q14</a></td><td headers="hd_b_cda1.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9Y2V0" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Protein C15orf41</a></td><td headers="hd_b_cda1.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_cda1.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=C15orf41" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">C15orf41</a></td><td headers="hd_b_cda1.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=C15orf41[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">C15orf41</a></td></tr><tr><td headers="hd_b_cda1.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/146059" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CDAN1</i></a></td><td headers="hd_b_cda1.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=146059" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">15q15<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_cda1.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q8IWY9" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Codanin-1</a></td><td headers="hd_b_cda1.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/CDAN1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CDAN1 database</a></td><td headers="hd_b_cda1.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CDAN1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CDAN1</a></td><td headers="hd_b_cda1.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CDAN1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CDAN1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="cda1.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="cda1.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Congenital Dyserythropoietic Anemia Type I (<a href="/omim/224120,607465,615626,615631" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK5313/table/cda1.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cda1.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/224120" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">224120</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607465" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607465</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CODANIN 1; CDAN1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615626" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615626</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHROMOSOME 15 OPEN READING FRAME 41; C15ORF41</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615631" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615631</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B</td></tr></tbody></table></div></div><p><b><i>C15orf41</i></b></p><p><b>Gene structure.</b>
<i>C15orf41</i> has been confirmed to generate a spliced transcript of 11 exons in cultured erythroblasts corresponding to <a href="/nuccore/NM_001130010.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001130010.1</a> [<a class="bk_pop" href="#cda1.REF.babbs.2013.1383">Babbs et al 2013</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK5313/#cda1.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> A pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant (p.Leu178Gln) was identified in one family originating in Kuwait. One <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (p.Tyr94Cys) with a possible <a class="def" href="/books/n/gene/glossary/def-item/founder-effect/">founder effect</a> was identified in two families of South Asian (Pakistani) descent [<a class="bk_pop" href="#cda1.REF.babbs.2013.1383">Babbs et al 2013</a>].</p><div id="cda1.T.c15orf41_pathogenic_variants_disc" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>C15orf41</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK5313/table/cda1.T.c15orf41_pathogenic_variants_disc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cda1.T.c15orf41_pathogenic_variants_disc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cda1.T.c15orf41_pathogenic_variants_disc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cda1.T.c15orf41_pathogenic_variants_disc_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cda1.T.c15orf41_pathogenic_variants_disc_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cda1.T.c15orf41_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.281A&#x0003e;G</td><td headers="hd_h_cda1.T.c15orf41_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr94Cys (South Asian)</td><td headers="hd_h_cda1.T.c15orf41_pathogenic_variants_disc_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_001130010.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001130010<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/protein/NP_001123482.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001123482<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_cda1.T.c15orf41_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.533T&#x0003e;A</td><td headers="hd_h_cda1.T.c15orf41_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu178Gln (Kuwaiti <a class="def" href="/books/n/gene/glossary/def-item/pedigree/">pedigree</a>)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The transcript variant <a href="/nuccore/NM_001130010.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001130010.1</a> encodes the 281-amino acid protein (<a href="/protein/NP_001123482.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001123482.1</a>) that is a novel restriction endonuclease of the Holliday junction resolvase protein family [<a class="bk_pop" href="#cda1.REF.babbs.2013.1383">Babbs et al 2013</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The mutated residues are both predicted to affect protein stability [<a class="bk_pop" href="#cda1.REF.babbs.2013.1383">Babbs et al 2013</a>].</p><p><b><i>CDAN1</i></b></p><p><b>Gene structure.</b>
<i>CDAN1</i> consists of 28 exons spanning 15 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. It encompasses a putative <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> of 4738 nucleotides encoding a protein of 1226 amino acids. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK5313/#cda1.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Most pathogenic variants (23/36) are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>. Other types of pathogenic variants identified to date include: five frameshift, four stop codon, and four <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants. No <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual was found to be <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a>-type variants. Most pathogenic variants (28/36) are found on the 3' half of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>; most are in exons 14 and 24.</p><p>Fourteen pathogenic variants are recurring, including the following from Europe:</p><ul><li class="half_rhythm"><div>c.2012C&#x0003e;T (9/75, 12% of mutated alleles)</div></li><li class="half_rhythm"><div>c.3389C&#x0003e;T (5/75, 7% of mutated alleles)</div></li><li class="half_rhythm"><div>c.3128A&#x0003e;T (4/75, 5% of mutated alleles)</div></li></ul><p>And the following from Europe and China:</p><ul><li class="half_rhythm"><div>c.2140C&#x0003e;T (4/75, 5% of mutated alleles)</div></li></ul><p>The Bedouin <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, c.3124C&#x0003e;T, was recently found in a French individual of European ancestry.</p><p>In 28% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals only one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CDAN1</i> has been identified, and in 12% of affected individuals no pathogenic variant in <i>CDAN1</i> has been identified; however, in most individuals <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> or large deletions have not been ruled out.</p><div id="cda1.T.selected_cdan1_variants" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>CDAN1</i> Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK5313/table/cda1.T.selected_cdan1_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cda1.T.selected_cdan1_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cda1.T.selected_cdan1_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Classification</th><th id="hd_h_cda1.T.selected_cdan1_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cda1.T.selected_cdan1_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cda1.T.selected_cdan1_variants_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Benign</b></td><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.320A&#x0003e;T</td><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln107Leu</td><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_4" rowspan="10" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/57222569" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_138477<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/57222570" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_612486<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.386G&#x0003e;A</td><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg129His</td></tr><tr><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1787A&#x0003e;G</td><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln596Arg</td></tr><tr><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2671C&#x0003e;T</td><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg891Cys</td></tr><tr><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_1" rowspan="6" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pathogenic</b></td><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.156C&#x0003e;G</td><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe52Leu</td></tr><tr><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2012C&#x0003e;T</td><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro671Leu</td></tr><tr><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2140C&#x0003e;T</td><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg714Trp</td></tr><tr><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.3124C&#x0003e;T</td><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg1042Trp&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.3128A&#x0003e;T</td><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp1043Val</td></tr><tr><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.3389C&#x0003e;T</td><td headers="hd_h_cda1.T.selected_cdan1_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro1130Leu</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="cda1.TF.3.1"><p class="no_margin">In persons of Bedouin ancestry</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The function of the gene product, codanin-1 protein, is as yet unknown. It has 1226 amino acids [<a class="bk_pop" href="#cda1.REF.ahmed.2006.4968">Ahmed et al 2006</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> It is not known how abnormal codanin-1 causes the disorder, but it is thought to result from loss of normal protein function. Molecular genetic testing has shown that <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have at least one mutated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> that is predicted to result in a translated protein product, suggesting that the codanin-1 protein may be essential for life.</p></div><div id="cda1.References"><h2 id="_cda1_References_">References</h2><div id="cda1.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cda1.REF.ahmed.2006.4968">Ahmed MR, Chehal A, Zahed L, Taher A, Haidar J, Shamseddine A, O'Hea AM, Bienz N, Dgany O, Avidan N, Beckmann JS, Tamary H, Higgs D, Vyas P, Wood WG, Wickramasinghe SN. Linkage and mutational analysis of the CDAN1 gene reveals genetic heterogeneity in congenital dyserythropoietic anemia type I. <span><span class="ref-journal">Blood. </span>2006;<span class="ref-vol">107</span>:4968–9.</span> [<a href="/pubmed/16754775" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16754775</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cda1.REF.ayas.2002.681">Ayas M, al-Jefri A, Baothman A, et al.  Transfusion-dependent congenital dyserythropoietic anemia type I successfully treated with allogeneic stem cell transplantation. <span><span class="ref-journal">Bone Marrow Transplant. </span>2002;<span class="ref-vol">29</span>:681–2.</span> [<a href="/pubmed/12180113" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12180113</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cda1.REF.babbs.2013.1383">Babbs C, Roberts NA, Sanchez-Pulido L, McGowan SJ, Ahmed MR, Brown JM, Sabry MA., WGS500 Consortium.  Bentley DR, McVean GA, Donnelly P, Gileadi O, Ponting CP, Higgs DR, Buckle VJ. Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I. <span><span class="ref-journal">Haematologica. </span>2013;<span class="ref-vol">98</span>:1383–7.</span> [<a href="/pmc/articles/PMC3762094/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3762094</span></a>] [<a href="/pubmed/23716552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23716552</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cda1.REF.frimmel.2016.482">Frimmel S, Kniestedt C. Angioid streaks in types I and II congenital dyserythropoietic anaemia (CDA). <span><span class="ref-journal">Klin Monbl Augenheilkd. </span>2016;<span class="ref-vol">233</span>:482–7.</span> [<a href="/pubmed/27116514" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27116514</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cda1.REF.heimpel.2003.4576">Heimpel H, Anselstetter V, Chrobak L, Denecke J, Einsiedler B, Gallmeier K, Griesshammer A, Marquardt T, Janka-Schaub G, Kron M, Kohne E. Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. <span><span class="ref-journal">Blood. </span>2003;<span class="ref-vol">102</span>:4576–81.</span> [<a href="/pubmed/12933587" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12933587</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cda1.REF.heimpel.2006.334">Heimpel H, Schwarz K, Ebn&#x000f6;ther M, Goede JS, Heydrich D, Kamp T, Plaumann L, Rath B, Roessler J, Schildknecht O, Schmid M, Wuillemin W, Einsiedler B, Leichtle R, Tamary H, Kohne E. Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation. <span><span class="ref-journal">Blood. </span>2006;<span class="ref-vol">107</span>:334–40.</span> [<a href="/pubmed/16141353" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16141353</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cda1.REF.lavabrebertrand.2004.380">Lavabre-Bertrand T, Ramos J, Delfour C, Henry L, Guiraud I, Carillo S, Wagner A, Bureau JP, Blanc P. Long-term alpha interferon treatment is effective on anaemia and significantly reduces iron overload in congenital dyserythropoiesis type I. <span><span class="ref-journal">Eur J Haematol. </span>2004;<span class="ref-vol">73</span>:380–3.</span> [<a href="/pubmed/15458519" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15458519</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cda1.REF.roberts.2006.456">Roberts E, Madhusudhana KC, Newsom R, Cullis JO. Blindness due to angioid streaks in congenital dyserythropoietic anaemia type I. <span><span class="ref-journal">Br J Haematol. </span>2006;<span class="ref-vol">133</span>:456.</span> [<a href="/pubmed/16681633" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16681633</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cda1.REF.schwarz.2009.936">Schwarz K, Iolascon A, Verissimo F, Trede NS, Horsley W, Chen W, Paw BH, Hopfner KP, Holzmann K, Russo R, Esposito MR, Spano D, De Falco L, Heinrich K, Joggerst B, Rojewski MT, Perrotta S, Denecke J, Pannicke U, Delaunay J, Pepperkok R, Heimpel H. Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>:936–40.</span> [<a href="/pubmed/19561605" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19561605</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cda1.REF.shalev.2017.13">Shalev H, Al-Athamen K, Levi I, Levitas A, Tamary H. Morbidity and mortality of adult patients with congenital dyserythropoietic anemia type I. <span><span class="ref-journal">Eur J Haematol. </span>2017;<span class="ref-vol">98</span>:13–8.</span> [<a href="/pubmed/27206021" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27206021</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cda1.REF.shalev.2008.317">Shalev H, Avraham GP, Hershkovitz R, Levy A, Sheiner E, Levi I, Tamary H. Pregnancy outcome in congenital dyserythropoietic anemia type I. <span><span class="ref-journal">Eur J Haematol. </span>2008;<span class="ref-vol">81</span>:317–21.</span> [<a href="/pubmed/18573172" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18573172</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cda1.REF.shalev.2004.746">Shalev H, Kapelushnik J, Moser A, Dgany O, Krasnov T, Tamary H. A comprehensive study of the neonatal manifestations of congenital dyserythropoietic anemia type I. <span><span class="ref-journal">J Pediatr Hematol Oncol. </span>2004;<span class="ref-vol">26</span>:746–8.</span> [<a href="/pubmed/15543010" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15543010</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cda1.REF.taher.2013">Taher A, Vichinsky E, Musallam K, et al. Iron overload and chelation therapy. In: Weatherall D, ed. <em>Guidelines for the Management of Non Transfusion Dependent Thalassaemia (NTDT)</em> Chap 5. Nicosia, Cyprus: Thalassaemia International Federation; 2013. Available <a href="/books/NBK190440/" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. Accessed 4-18-18.</div></li><li class="half_rhythm"><div class="bk_ref" id="cda1.REF.tamary.2008.271">Tamary H, Offret H, Dgany O, Foliguet B, Wickramasinghe SN, Krasnov T, Rumilly F, Goujard C, F&#x000e9;n&#x000e9;ant-Thibault M, Cynober T, Delaunay J. Congenital dyserythropoietic anaemia, type I, in a Caucasian patient with retinal angioid streaks (homozygous Arg1042Trp mutation in codanin-1). <span><span class="ref-journal">Eur J Haematol. </span>2008;<span class="ref-vol">80</span>:271–4.</span> [<a href="/pubmed/18081704" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18081704</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cda1.REF.wickramasinghe.2005.431">Wickramasinghe SN, Wood WG. Advances in the understanding of the congenital dyserythropoietic anaemias. <span><span class="ref-journal">Br J Haematol. </span>2005;<span class="ref-vol">131</span>:431–46.</span> [<a href="/pubmed/16281933" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16281933</span></a>]</div></li></ul></div><div id="cda1.Suggested_Reading"><h3>Suggested Reading</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cda1.REF.heimpel.2006">Heimpel H, Iolascon A. Congenital dyserythropoietic anemia. In: Beaumont C, Beris Ph, Beuzard Y, Brugnara C, eds. <em>Disorders of Homeostasis, Erythrocytes, Erythropoiesis</em>. Paris, France: European School of Haematology; 2006:120-42.</div></li></ul></div></div><div id="cda1.Chapter_Notes"><h2 id="_cda1_Chapter_Notes_">Chapter Notes</h2><div id="cda1.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>25 August 2016 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>20 February 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>1 September 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>21 April 2009 (et) Review posted live</div></li><li class="half_rhythm"><div>12 November 2008 (ht) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK5313</span><span class="label">PMID: <a href="/pubmed/20301759" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301759</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cdg/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cep/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK5313&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK5313/?report=reader">PubReader</a></li><li><a href="/books/NBK5313/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK5313" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK5313" style="display:none" title="Cite this Page"><div class="bk_tt">Tamary H, Dgany O. Congenital Dyserythropoietic Anemia Type I. 2009 Apr 21 [Updated 2016 Aug 25]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK5313/pdf/Bookshelf_NBK5313.pdf">PDF version of this page</a> (411K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#cda1.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#cda1.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#cda1.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#cda1.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#cda1.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#cda1.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#cda1.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#cda1.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#cda1.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#cda1.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#cda1.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=146059[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CDAN1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=84529[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">C15orf41</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK5313+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1469674" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1469674" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1469674" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1469674" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301599" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Beta-Thalassemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Beta-Thalassemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Origa R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24624460" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">EPB42</i>-Related Hereditary Spherocytosis</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">EPB42</i>-Related Hereditary Spherocytosis<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kalfa TA, Connor JA, Begtrup AH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301608" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alpha-Thalassemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alpha-Thalassemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Origa R, Moi P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301769" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Diamond-Blackfan Anemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Diamond-Blackfan Anemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Clinton C, Gazda HT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301349" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Juvenile Hereditary Hemochromatosis</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Juvenile Hereditary Hemochromatosis<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Goldberg YP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301759" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301759" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040d8edde089116954dcf4">Congenital Dyserythropoietic Anemia Type I - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Congenital Dyserythropoietic Anemia Type I - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:31:58-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE888AD1E03F3CE1000000000959033D&amp;ncbi_session=CE888AD1E040D8E1_2393SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK5313%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK5313&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK5313/&amp;ncbi_pagename=Congenital Dyserythropoietic Anemia Type I - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE888AD1E040D8E1_2393SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>